OBESITY, DIABETES AND CORONARY HEART DISEASES

N. Vujačić
N. Vujačić

Health center - Kosovska Mitrovica

Published: 01.01.2004.

Volume 32, Issue 1 (2004)

pp. 43-47;

https://doi.org/10.70949/pramed200401057V

Abstract

The clinical and metabolic anomalies observed in patients with type 2 diabetes are associated with high risk of cardiovascular disease (particulary coronary heart disease), witch is responsible for 75% of all death in diabetic patients. Diabetic people have cardiovascular risk factors comparable to those of nondiabetics who have had myocardial infarction or stroke. To determine main risk factors for coronary heart desease (CHD) and differentes among diabetics we analyzed 86 patients.Patients in this study attended in Institute of endocrynology,diabetes and matabolic disorders in Belgrade. The diagnosis was based on typical clinical manifestation: high levels of glucose (higher than 6,1mmol/l), high cholesterol and tryglicerides, hypertension and overweight. In the control group we have had 20 adult, healty people without metabolic disorders. We found that diabetics with coronary heart disease have had the higest level of glucose (13,2mmol/l), cholesterol (6,96mmol/l),tryglicerides (2,84mmol/l). Arterial hypertension in the group of diabetic patientes with CHD have had 72,7 %, or 40 patients of 55 patients of whole group. Type 2 diabetes and hypertension share certain risk factors such as overweight, visceral obesity,and possibly insulin resistence. This study strenthgenes the hypothesis that cholesterol and the arterial hypertension have central role in develpoment of CHD, but in non-insulin depended diabetics they associated with metabolic disorders witch play an important role in increasing the risk of coronary heart disease.

Keywords

References

1.
Packard C, Olason AG. Management of Hypercholesterolemia in Patients with Diabetes. Int J Clin Pract Suppl.
2.
Yoshino G, Hirano T, Kzumi T. Atherogenic Lipoproteins and Diabetes Mellitus. J Diabetes Complications. 16(1):29–34.
3.
Wolffenbuttel BH, Heine RJ. Glycemic Regulation and Management of Essential Hypertension in Diabetics with Type 2 Diabetes Mellitus. Ned Tijdschr Geneeskd. 5:143.
4.
Viberti G. The Need for Strict Control of Cardiovascular Risk Factors in Type 2 Diabetic Patients. Presse Med. c(2):5–8.
5.
Teuscher A, Diem P. Treatment of Hypertension in Type 2 Diabetes Mellitus: 2002 Update. Ther Umsch. 59(8):422–8.
6.
Taskinen MR. Diabetic Dyslipidemia and Atherosclerosis. Suppl. 3(1):47–51.
7.
Stout RW. Diabetes and Atherosclerosis. Biomed Pharmacother. 47(1):1–2.
8.
Steg PG, Karila Cohen D, Feldman LJ. The Coronary Atherosclerosis of Diabetes.
9.
Rapp RJ. Hypertriglyceridemia: A Review Beyond Low-Density Lipoprotein. Cardiol Rev. 10(3):163–72.
10.
Reaven GM. Multiple CHD Risk Factors in Type 2 Diabetes, Beyond Hyperglycemia. Diabetes Obes Metab. 4 Suppl 1:13–8.
11.
Donnan PT, Boyle DI, Broomhall J, Hunter K, MacDonald TM, Newton RW. Morris AD: Prognosis Following First Acute Myocardial Infarction in Type 2 Diabetes: A Comparative Study. Diabet Med. 19(6):448–55.
12.
Mykkanen L. Prevention of Coronary Heart Disease in Type 2 Diabetes. Int J Clin Pract Suppl.
13.
McLoughlin T, Reaven G. Insulin Resistance and Hypertension: Patients in Double Jeopardy for Cardiovascular Disease. Geriatrics. 55(6):35.
14.
Dragan M. str. 12:27, 42.
15.
Landsberg L. Insulin Resistance and Hypertension. Clin Exp Hypertens. 21(5–6):885–94.
16.
Kaur J, Singh P, Sowers. Diabetes and Cardiovascular Diseases. Am J The.
17.
Janeczko D, Kopczynski J, Lewandowski Z, Janeczko-Sosnowska E, Tuszynska A. Title not provided. Przegl Lek. 4:3–7.
18.
I GM, I RR, E AR, J PB, I GL. Arterial Hypertension and Disorders of Hydrocarbon Metabolism. Rev Esp Cardiol. 4:3–14.
19.
Frolich J, Steiner G. Dyslipidemia and Coagulation Defects of Insulin Resistance. Int J Clin Pract Suppl.
20.
Erkelens DW. Insulin Resistance Syndrome in Type 2 Diabetes Mellitus. Am J Cardiol. 11:88.

Citation

Copyright

Article metrics

Google scholar: See link

The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Most read articles

Indexed by